EMPROS PHARMA AB

City:

Solna

Country:

Sweden

Published Applications:

Last publication date:

2025-04-24

Patent Grants:

Last grant date:

2026-05-19

Top Inventors for applications by EMPROS PHARMA AB

These are the the leading inventors for applications assigned to EMPROS PHARMA AB:

Göran Alderborn 5 Uppsala, Sweden
Anders Forslund 5 Uppsala, Sweden
Hans Lennernäs 3 Uppsala, Sweden
Jan Stefan Persson Grudén 3 Uppsala, Sweden

Ulf Holmbäck 3 Uppsala, Sweden
Jan Arvid SÖDERHALL 2 Spånga, Sweden
Jan Stefan Persson GRUDÉN 2 Uppsala, Sweden
Ulf HOLMBÄCK 2 Uppsala, Sweden

Recent patent applications by EMPROS PHARMA AB

EMPROS PHARMA AB based in Solna, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-04-24

US20250127752A1

Human necessities

REDUCED REBOUND EFFECTS IN SUBJECTS TREATED FOR OVERWEIGHT OR OBESITY

#2 | 2024-10-17 ✅ Patent 12,629,340 granted on 2026-05-19

US20240342096A1

Human necessities

MODIFIED RELEASE COMPOSITION OF ORLISTAT AND ACARBOSE FOR THE TREATMENT OF OBESITY AND RELATED METABOLIC DISORDERS

#3 | 2024-07-11

US20240226024A1

Human necessities

SYNERGISTIC EFFECTS ON WEIGHT LOSS, IMPROVED QUALITY OF LIFE AND REDUCED GASTRO-INTESTINAL SIDE EFFECTS WITH A COMPOSITION OF ORLISTAT AND ACARBOSE

#4 | 2020-07-23 ✅ Patent 11,975,105 granted on 2024-05-07

US20200230063A1

Human necessities

Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders

#5 | 2017-12-21 ✅ Patent 10,561,617 granted on 2020-02-18

US20170360715A1

Human necessities

Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders

Also check out EMPROS PHARMA AB's (Solna, Sweden) applicant profile with 5 patent applications submitted.

AssigneeID:

130164 ⎘